HDAC1 and neoplasm: As shown in Figure 4I, for the groups treated with FA/MoS2 + NIR, FA/MoS2/si(HDAC1+Kras) and FA/MoS2/si(HDAC1+Kras) (NIR), the final tumor volumes were 8, 6, and 3 times of that of the original tumor volume while the control group's was 20 times of the original tumor.